Newsroom
December 15, 2022
American Federation for Aging Research grant allows exploration of signaling molecules toxic in Alzheimer’s, diabetes, aging Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO (Dec. 15, 2022) — The American Federation for Aging Research (AFAR) selected Juan Pablo Palavicini, PhD, an early career scientist at The University of Texas Health Science Center at San Antonio (UT […]
December 8, 2022
The AHEAD clinical trial will assess whether the new Alzheimer’s drug, lecanemab, can delay the onset of dementia in persons who are at high risk of developing the disease. The Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, part of The University of Texas Health Science Center at San Antonio (UT Health San Antonio), […]
October 12, 2022
The NIA Interventions Testing Program, including UT Health San Antonio, collaborated with peers in Tennessee and Switzerland. Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (Oct. 12, 2022) — Researchers from the National Institute on Aging (NIA)-funded Interventions Testing Program recently reported the discovery of multiple candidate genes that influence longevity. The three Interventions Testing Program […]
